Citace záznamu

Citace podle APA (7th ed.)
H, A., B, S., S, K., HJ, B., H, B. H., A, T., . . . T, R. (2024). Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country. Dove Medical Press.
Citace podle Chicago (17th ed.)
H, Abdel-Razeq, et al. Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country. Dove Medical Press, 2024.
Citace podle MLA (9th ed.)
H, Abdel-Razeq, et al. Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country. Dove Medical Press, 2024.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..